Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni

BACKGROUND: As plans to expand mass drug treatment campaigns to fight schistosomiasis form, worries about reliance on praziquantel as the sole available treatment motivate the investigation for novel antischistosomal compounds. Drug repurposing might be an inexpensive and effective source of novel a...

Descripción completa

Detalles Bibliográficos
Autores principales: Panic, Gordana, Vargas, Mireille, Scandale, Ivan, Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521867/
https://www.ncbi.nlm.nih.gov/pubmed/26230921
http://dx.doi.org/10.1371/journal.pntd.0003962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521867/
https://www.ncbi.nlm.nih.gov/pubmed/26230921
http://dx.doi.org/10.1371/journal.pntd.0003962

Ejemplares similares